Eris Lifesciences (BOM:540596) FFO


BOM:540596 Eris Lifesciences Ltd BOM:540596
92 GF Score
Price ₹1,412.90
GF Value ₹1,641.89
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Eris Lifesciences FFO?

FFO (Funds from operations) only applies to REITs.

BOM:540596
92GF Score
Eris Lifesciences Ltd BOM:540596
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eris Lifesciences (BOM:540596) Overvalued in 2026?

Based on GuruFocus' analysis, Eris Lifesciences stock appears to be undervalued. The current stock price of ₹1,412.90 is trading 13.9% below its estimated GF Value™ of ₹1,641.89. GuruFocus considers Eris Lifesciences to be Modestly Undervalued.

Key valuation signals for BOM:540596:

  • FFO:
  • GF Value™: ₹1,641.89 vs. price of ₹1,412.90 (13.9% below fair value)
  • GF Score™: 92/100 with 6 warning signs

No single metric tells the full story. See the BOM:540596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eris Lifesciences Business Description

Other Exchanges ERIS:India
Address Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast. The company works basically within India and International with the majority of revenue from India.
92GF Score

Get the complete analysis for BOM:540596

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,412.90
Price
₹1,641.89
GF Value